454 related articles for article (PubMed ID: 22338175)
21. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.
Capello D; Guarini A; Berra E; Mauro FR; Rossi D; Ghia E; Cerri M; Logan J; Foà R; Gaidano G
Leukemia; 2004 Dec; 18(12):1941-7. PubMed ID: 15483675
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
[TBL] [Abstract][Full Text] [Related]
23. Immunogenetics of chronic lymphocytic leukemia.
Patkar N; Rabade N; Kadam PA; Mishra F; Muranjan A; Tembhare P; Chaudhary S; Joshi S; Jain H; Dangi U; Bagal B; Khattry N; Menon H; Gujral S; Sengar M; Subramanian PG
Indian J Pathol Microbiol; 2017; 60(1):38-42. PubMed ID: 28195089
[TBL] [Abstract][Full Text] [Related]
24. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.
Tobin G; Thunberg U; Johnson A; Eriksson I; Söderberg O; Karlsson K; Merup M; Juliusson G; Vilpo J; Enblad G; Sundström C; Roos G; Rosenquist R
Blood; 2003 Jun; 101(12):4952-7. PubMed ID: 12586612
[TBL] [Abstract][Full Text] [Related]
25. [Clonality analysis and mutation status of IgVH genes in classic Richter's syndrome].
Mao ZR; Rosenwald A; Zhang SJ; Zhou R; Mueller-Hermelink HK
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):364-70. PubMed ID: 19031714
[TBL] [Abstract][Full Text] [Related]
26. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
27. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia.
Ritgen M; Lange A; Stilgenbauer S; Dohner H; Bretscher C; Bosse H; Stuhr A; Kneba M; Dreger P
Blood; 2003 Mar; 101(5):2049-53. PubMed ID: 12411304
[TBL] [Abstract][Full Text] [Related]
28. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.
Johnson TA; Rassenti LZ; Kipps TJ
J Immunol; 1997 Jan; 158(1):235-46. PubMed ID: 8977195
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes.
Porakishvili N; Kulikova N; Jewell AP; Youinou PY; Yong K; Nathwani A; Heelan B; Duke V; Hamblin TJ; Wallace P; Ely P; Clark EA; Lydyard PM
Br J Haematol; 2005 Nov; 131(3):313-9. PubMed ID: 16225650
[TBL] [Abstract][Full Text] [Related]
30. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome.
Timár B; Fülöp Z; Csernus B; Angster C; Bognár A; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2004 Feb; 18(2):326-30. PubMed ID: 14671632
[TBL] [Abstract][Full Text] [Related]
31. [Molecular genetic characterization of chronic lymphocytic leukemia aggressivity in Czech patients: a nucleotide variability of genes coding for heavy chain of immunoglobulin].
Kuhrová V; Francová H; Klimesová D; Brychtová Y; Doubek M; Trbusek M; Brejcha M; Dvoráková D; Mayer J
Cas Lek Cesk; 2006; 145(11):855-8; discussion 859-60. PubMed ID: 17168419
[TBL] [Abstract][Full Text] [Related]
32. Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
Terrin L; Trentin L; Degan M; Corradini I; Bertorelle R; Carli P; Maschio N; Bo MD; Noventa F; Gattei V; Semenzato G; De Rossi A
Leukemia; 2007 May; 21(5):965-72. PubMed ID: 17344921
[TBL] [Abstract][Full Text] [Related]
33. The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.
Francis S; Karanth M; Pratt G; Starczynski J; Hooper L; Fegan C; Pepper C; Valcarcel D; Milligan DW; Delgado J
Cancer; 2006 Sep; 107(5):1023-33. PubMed ID: 16862572
[TBL] [Abstract][Full Text] [Related]
34. Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.
Ricca I; Rocci A; Drandi D; Francese R; Compagno M; Lobetti Bodoni C; De Marco F; Astolfi M; Monitillo L; Vallet S; Calvi R; Ficara F; Omedè P; Rosato R; Gallamini A; Marinone C; Bergui L; Boccadoro M; Tarella C; Ladetto M
Leukemia; 2007 Apr; 21(4):697-705. PubMed ID: 17301820
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
[TBL] [Abstract][Full Text] [Related]
36. [Characteristics of malignant clone from acute lymphocytic leukemia].
Zhu P; Liu J
Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1057-61. PubMed ID: 11758256
[TBL] [Abstract][Full Text] [Related]
37. Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.
Aoun P; Zhou G; Chan WC; Page C; Neth K; Pickering D; Sanger W; Quinn-Laquer B; Watson P; Lynch JF; Lynch HT; Weisenburger DD
Am J Clin Pathol; 2007 Jan; 127(1):31-8. PubMed ID: 17145621
[TBL] [Abstract][Full Text] [Related]
38. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
[TBL] [Abstract][Full Text] [Related]
39. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments.
Perez M; Pacchiarotti A; Frontani M; Pescarmona E; Caprini E; Lombardo GA; Russo G; Faraggiana T
Br J Dermatol; 2010 Mar; 162(3):611-8. PubMed ID: 19906071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
